182 related articles for article (PubMed ID: 26339344)
41. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
Baraniskin A; Deckert M; Schulte-Altedorneburg G; Schlegel U; Schroers R
Br J Haematol; 2012 Feb; 156(4):421-32. PubMed ID: 22077417
[TBL] [Abstract][Full Text] [Related]
42. Primary central nervous system lymphoma: a review.
McAllister LD
Curr Neurol Neurosci Rep; 2002 May; 2(3):210-5. PubMed ID: 11936999
[TBL] [Abstract][Full Text] [Related]
43. Primary central nervous system lymphoma.
Bhagavathi S; Wilson JD
Arch Pathol Lab Med; 2008 Nov; 132(11):1830-4. PubMed ID: 18976024
[TBL] [Abstract][Full Text] [Related]
44. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
[TBL] [Abstract][Full Text] [Related]
45. The Impact of Early Corticosteroid Pretreatment Before Initiation of Chemotherapy in Patients With Primary Central Nervous System Lymphoma.
Gessler F; Bernstock JD; Behmanesh B; Brunnberg U; Harter P; Ye D; Friedman GK; Hansmann ML; Wagner M; Seifert V; Weise L; Marquardt G
Neurosurgery; 2019 Aug; 85(2):264-272. PubMed ID: 30016483
[TBL] [Abstract][Full Text] [Related]
46. An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients.
Scheichel F; Pinggera D; Popadic B; Sherif C; Marhold F; Freyschlag CF
Front Oncol; 2022; 12():884724. PubMed ID: 35515113
[TBL] [Abstract][Full Text] [Related]
47. Computerized morphometric analysis of human leukemic and lymphomatous cells in various histological environments of central nervous system.
Nowacki P; Zdziarska B; Grzelec H
Folia Neuropathol; 1999; 37(3):189-94. PubMed ID: 10581857
[TBL] [Abstract][Full Text] [Related]
48. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?
O'Neill BP; Dinapoli RP; Kurtin PJ; Habermann TM
J Neurooncol; 1995; 25(1):67-71. PubMed ID: 8523091
[TBL] [Abstract][Full Text] [Related]
49. Preoperative Corticosteroids Reduce Diagnostic Accuracy of Stereotactic Biopsies in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis.
Tosefsky K; Rebchuk AD; Martin KC; Chen DW; Yip S; Makarenko S
Neurosurgery; 2024 Apr; ():. PubMed ID: 38865324
[TBL] [Abstract][Full Text] [Related]
50. Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation.
Yamaguchi S; Hirata K; Kaneko S; Kobayashi H; Shiga T; Kobayashi K; Onimaru R; Shirato H; Tamaki N; Terasaka S; Houkin K
Acta Neurochir (Wien); 2015 Feb; 157(2):187-94. PubMed ID: 25488176
[TBL] [Abstract][Full Text] [Related]
51. Inflammatory demyelinating brain lesions heralding primary CNS lymphoma.
Husseini L; Saleh A; Reifenberger G; Hartung HP; Kieseier BC
Can J Neurol Sci; 2012 Jan; 39(1):6-10. PubMed ID: 22384490
[TBL] [Abstract][Full Text] [Related]
52. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
King RL; Goodlad JR; Calaminici M; Dotlic S; Montes-Moreno S; Oschlies I; Ponzoni M; Traverse-Glehen A; Ott G; Ferry JA
Virchows Arch; 2020 May; 476(5):647-665. PubMed ID: 31863183
[TBL] [Abstract][Full Text] [Related]
53. The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death.
Molnár PP; O'Neill BP; Scheithauer BW; Groothuis DR
Neuro Oncol; 1999 Apr; 1(2):89-100. PubMed ID: 11550310
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme.
Cerqua R; Balestrini S; Perozzi C; Cameriere V; Renzi S; Lagalla G; Mancini G; Montanari M; Leoni P; Scerrati M; Iacoangeli M; Silvestrini M; Luzzi S; Provinciali L
Neurol Sci; 2016 Jan; 37(1):23-29. PubMed ID: 26233232
[TBL] [Abstract][Full Text] [Related]
55. Cell-Block cytology in diagnosis of primary central nervous system lymphoma: A case report.
Huang K; Zhou L; Tong Y
Medicine (Baltimore); 2020 Apr; 99(14):e19598. PubMed ID: 32243381
[TBL] [Abstract][Full Text] [Related]
56. Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
Zhao D; Qian L; Shen J; Liu X; Mei K; Cen J; Wang Y; Li C; Ma Y
J Cell Mol Med; 2014 Jun; 18(6):1081-6. PubMed ID: 24628986
[TBL] [Abstract][Full Text] [Related]
57. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
[TBL] [Abstract][Full Text] [Related]
58. Sentinel lesions of primary CNS lymphoma.
Alderson L; Fetell MR; Sisti M; Hochberg F; Cohen M; Louis DN
J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):102-5. PubMed ID: 8558135
[TBL] [Abstract][Full Text] [Related]
59. Clinical utility of brain biopsy for presumed CNS relapse of systemic lymphoma.
Brown DA; Goyal A; Richter KR; Haglin JM; Himes BT; Lu VM; Snyder K; Hughes J; Decker PA; Opoku-Darko M; Link MJ; Burns TC; Parney IF
J Neurosurg; 2022 Jan; 136(1):30-39. PubMed ID: 34214988
[TBL] [Abstract][Full Text] [Related]
60. [Characteristic imaging features of primary central nervous system lymphoma in comparison with pathological findings].
Liu HY; Zhang XL; Chen YP; Qiu SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):333-6. PubMed ID: 19246316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
